Wednesday, February 10, 2010, 4:54am EST - Canadian Markets open in 4 hours and 36 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Alcon Inc. (ACL)

On Feb 9: 157.46 USD   0.00 (0.00%)  
MORE ON ACL
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials
Profile Get Profile for:
Alcon Inc.
Bosch 69
PO Box 62
Hunenberg,  6331
Phone: 41 41 785 88 88
Fax: 41 41 785 88 87
Web Site: http://www.alconinc.com

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees (last reported count): 13,500

BUSINESS SUMMARY
Alcon, Inc. engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat eye diseases and disorders. It offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. The company's ophthalmic surgical products include surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. Its consumer eye care products consist of contact lens care products, such as disinfecting solutions, cleaners, weekly enzymatic cleaners, and lens rewetting drops; artificial tears to treat dry eye syndrome; and ocular vitamins, including dietary supplements, Lutein, and Zeaxanthin formula. The company markets its pharmaceutical products to distributors, wholesalers, hospitals, government agencies, large retailers, and physicians; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and contact lens care products to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It sells its products primarily in the United States, Japan, France, Spain, Canada, Germany, Italy, Brazil, the United Kingdom, Australia, and Mexico. The company was founded in 1945. It was formerly known as Société Fromagère Nestlé S.A. and changed its name to Alcon Universal S.A. in 1978. Further, the company changed its name to Alcon, Inc. in 2001. The company is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestlé S.A.
Key Statistics

COMPANY WEBSITES
  • Home Page
  • Search Yahoo! for:
    More on Alcon Inc.



    View Financials

    OFFICERS
      Pay Exercised
    Mr. Cary R. Rayment , 60
    Exec. Chairman, Chief Exec. Officer, Pres, Chairman of Alcon Laboratories Inc., Chief Exec. Officer of Alcon Laboratories Inc., Pres of Alcon Laboratories Inc. of Alcon Laboratories Inc
    $ 3.60M $ 3.00M
    Dr. Gerald D. Cagle , 63
    Chief Scientific Officer and Sr. VP of R&D of Alcon Laboratories Inc
    $ 3.62M $ 10.22M
    Mr. Kevin J. Buehler , 51
    Chief Marketing Officer and Sr. VP of Global Markets
    $ 880.00K $ 1.18M
    Mr. Francisco Castañer , 63
    Vice Chairman, Member of Nominating & Corp. Governance Committee, Member of Compensation Committee and Exec. VP of Pharmaceutical and Cosmetic Products
    N/A N/A
    Mr. Richard Croarkin ,
    Chief Financial Officer and Sr. VP
    N/A N/A
    Dollar amounts are as of 31-Dec-06 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.


    Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
    Get Profile for Another Symbol:
    Symbol Lookup
    Latest News Canadian Indices